Skip to main content
Clinical Trials/PACTR202208499106275
PACTR202208499106275
Not yet recruiting
Phase 1

ANALGESIC EFFICACY OF BUPIVACAINE VERSUS BUPIVACAINE PLUS MAGNESIUM SULPHATE IN TRANSVERSUS ABDOMINIS PLANE BLOCK FOLLOWING ABDOMINAL GYNAECOLOGICAL SURGERY

Olatunde Towobola0 sites74 target enrollmentAugust 9, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Benign and malignant Gynaecological diseases
Sponsor
Olatunde Towobola
Enrollment
74
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 9, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Olatunde Towobola

Eligibility Criteria

Inclusion Criteria

  • American Society of Anaesthesiologists physical status class I – III female adults scheduled for elective abdominal surgery

Exclusion Criteria

  • Patients’ refusal
  • History of relevant drug allergies
  • Patients on calcium channel blockers
  • Opioid dependence
  • Localised skin infection at site of block
  • Patient with sepsis
  • Patient with coagulation disorders
  • Obese patients with BMI \> 35kg/m2
  • Psychiatric illness that would interfere with the perception and assessment of pain
  • Intra operative finding of a frozen pelvis

Outcomes

Primary Outcomes

Not specified

Similar Trials